Senvelgo oral solution by Boehringer Ingelheim is a veterinary-prescribed medication formulated to help reduce hyperglycemia in cats with non-insulin dependent diabetes mellitus. This easy-to-administer oral solution contains velagliflozin L-proline monohydrate at 15 mg/mL. Available in 12 ml and 30 ml bottles (DIN 02543427), it supports veterinarian-directed diabetes management for cats. For use only under the guidance of a veterinarian; prescription required in Canada.